
India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says
NEW DELHI: India’s pharmaceutical industry is likely to miss its sales target for the end of the decade as U.S. tariff uncertainty and Middle East shipping disruptions weigh on exports, the head of a government-backed trade body told Reuters.





























.jpg)



























_20260303034444831_9420ca.webp)




















_20251003092603298_af0c50_20251010094012153_327c07.webp)



